‘Because there is more to do’ Report

Listening to people, patients, carers, patient groups and healthcare professionals

The 'Because there is more to do' report presents the results of this public listening initiative of Bristol Myers Squibb.

In late 2020, we opened two surveys to ask people for their feedback on health issues, and how they see the role of pharma companies in supporting patients beyond the provision of medicines. A public survey invited everyone across eight European countries to participate. Discover the findings in the ‘Because there is more to do’ report. 


Read the European Report
Read the European Report >

 – an overview of insights from across eight European countries. 

About the initiative
About the initiative >

We firmly believe we should always strive to do more to help patients, beyond the provision of medicines, and work in partnership across healthcare to enable this. Learn more about ‘Because there is more to do’.

Watch BMS Talks
Watch BMS Talks >

Watch our employees' response to the feedback from patients, carers, patient groups, healthcare professionals and people in general, in a series of personal video clips.